← Back to Search

Overheard Speech Learning for Autism

N/A
Waitlist Available
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 5 minutes
Awards & highlights

Study Summary

This trial is looking at whether children with ASD can learn from overheard conversations and if videoconferencing can help.

Who is the study for?
This trial is for children aged 18 to 71 months with or without Autism Spectrum Disorder (ASD), who speak English as their native language. It excludes those born prematurely, with photosensitive seizures, uncorrected hearing/vision issues, or other conditions affecting language/cognition besides ASD.Check my eligibility
What is being tested?
The study examines if children with ASD can learn words from conversations directed at them and those they overhear through videoconferencing. Typically developing children are also included for comparison.See study design
What are the potential side effects?
There are no direct physical side effects expected from this intervention as it involves educational techniques using speech and videoconferencing technology.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of time during which children's eye gaze is directed toward the target object

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OverheardExperimental Treatment1 Intervention
Children watch via video while an experimenter uses the word to be learned in an interaction with another experimenter.
Group II: AddressedActive Control1 Intervention
Children participate via video in an interaction with an experimenter who uses the word to be learned.

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
226 Previous Clinical Trials
313,960 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
1,334 Patients Enrolled for Autism Spectrum Disorder
Emerson CollegeOTHER
3 Previous Clinical Trials
421 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
334 Patients Enrolled for Autism Spectrum Disorder

Media Library

Addressed Speech Clinical Trial Eligibility Overview. Trial Name: NCT05192109 — N/A
Autism Spectrum Disorder Research Study Groups: Addressed, Overheard
Autism Spectrum Disorder Clinical Trial 2023: Addressed Speech Highlights & Side Effects. Trial Name: NCT05192109 — N/A
Addressed Speech 2023 Treatment Timeline for Medical Study. Trial Name: NCT05192109 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to join this experiment at the moment?

"As evidenced by the clinicaltrials.gov database, this experiment is not currently in need of participants; it was published on December 1st 2020 and had its last update on November 23rd 2021. Nonetheless, other trials are still recruiting patients - 271 to be exact."

Answered by AI

What criteria must potential participants fulfill in order to join this medical experiment?

"This investigation is searching for 295 individuals on the autism spectrum aged between 18 Months and 71 Months. To be eligible, subjects must meet certain criteria: children with an ASD diagnosis or not within the aforementioned age range."

Answered by AI

Are participants aged 35 or younger qualified to contribute to this clinical trial?

"This medical trial is currently accepting patients that are between 18 months and 71 months of age."

Answered by AI

Who else is applying?

What state do they live in?
Florida
What portion of applicants met pre-screening criteria?
Met criteria
~53 spots leftby Feb 2025